Both in Biotechnology
REGENXBIO vs Entera Bio
Over the past year RGNX returned −24.4% and ENTX returned +37.9%; their daily moves had a correlation of 0.08.
RGNX −24.4% ENTX +37.9%Growth of $1, one year, split-adjusted
| Metric | RGNX | ENTX |
|---|---|---|
| Price | $7.45 | $2.69 |
| Market cap | $491.8M | $465.8M |
| Today | −0.27% | 0.00% |
| 1 month | −22.9% | −11.2% |
| 6 months | −4.1% | +169.0% |
| Year to date | −48.3% | +38.7% |
| 1 year | −22.8% | +47.8% |
| Revenue growth (YoY) | +405.7% | — |
| Gross margin | 99.0% | — |
| Net margin | 21.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.8× | — |
| Net cash | $105.5M | $11.0M |
| Dividend yield | — | — |
| Volatility (60d) | 91.6% | 149.2% |
| Short % of float | 15.3% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).